Peptides
Learn
Tools
Providers
News
Find a provider
NEWS

Peptide therapy news

Regulatory moves, FDA actions, new research and what the industry does about it. The reporting lives on our editorial hub, PeptideWellness — every headline below opens there.

STUDY

Retatrutide beat Ozempic 2 mg in its first head-to-head trial

INDUSTRY

LegitScript will now certify sellers of six compounded peptides

DECISION

HHS lets pharmacies compound six peptides, with conditions

SAFETY

Two compounders recall GLP-1 injections over sterility

INDUSTRY

GLP-1 prices barely moved in 2026. Here is the data

INDUSTRY

GLP-1 muscle loss: what Nestle's new push reveals

ENFORCEMENT

FDA warning letters now reach research-peptide sellers

DECISION

FDA advisory panel overruled its reviewers on six of seven

PROPOSAL

FDA reviewers say no: seven peptides face 503A advisory vote

ENFORCEMENT

FDA cited 25 telehealth GLP-1 sellers in one wave